Ascendis Pharma

Ascendis Pharma (operating at ascendispharma.com) is a global biopharmaceutical company engineered for advancing innovative treatments in rare diseases and endocrine disorders. Founded in 2007 by Jan Møller Mikkelsen and headquartered in Copenhagen, Denmark, Ascendis Pharma specializes in addressing unmet medical needs where traditional therapies fall short. Under the hood, the company leverages its proprietary TransCon technology platform, designed to enhance the delivery and efficacy of peptide-based drugs by extending their half-life in the body. This allows patients with conditions like growth disorders, diabetes, and rare endocrine diseases to achieve more stable therapeutic outcomes with fewer injections. By focusing on rare disease and oncology programs, Ascendis Pharma targets underserved patient populations, offering life-changing solutions where conventional treatments often fail. The company operates across four continents, with research facilities in Germany and a global workforce dedicated to driving scientific innovation.